Table 3 Clinical and functional characteristics of IDC Cohort
From: A negative screen for mutations in calstabin 1 and 2 genes in patients with dilated cardiomyopathy
IDC Cohort | |
|---|---|
Clinical | |
Biochemical | |
Hemoglobin (mg/dL) | 12.7 ± 1.97 |
Total Cholesterol (mg/dL) | 185 ± 55 |
Triglycerides (mg/dL) | 106 ± 56 |
HDL (mg/dL) | 45.7 ± 17.3 |
LDL (mg/dL) | 116 ± 44 |
Creatinin (mg/dL) | 1.2 ± 0.3 |
BMI (kg/m2) | 25.08 ± 4.65 |
Heart Rate (pm) | 76.35 ± 13.57 |
Diastolic Blood Pressure (mmHg) | 67.41 ± 14.56 |
Systolic Blood Pressure (mmHg) | 104.44 ± 18.9 |
Echocardiographic | |
Left Atrium Diameter, mm | 47.52 ± 8.48 |
Aortic Diameter, mm | 32.57 ± 4.26 |
Right Ventricle Diameter, mm | 27.19 ± 6.14 |
Left Ventricle | |
Intraventricular Septum, mm | 8.39 ± 1.48 |
Posterior Wall Thickness, mm | 8.31 ± 1.21 |
Diastolic Diameter, mm | 73.55 ± 10.06 |
Systolic Diameter, mm | 64.01 ± 9.58 |
Ejection Fraction, (%) | 35.08 ± 8.9 |
Mass, g | 268.74 ± 77 |